Followers | 43 |
Posts | 4261 |
Boards Moderated | 0 |
Alias Born | 07/14/2010 |
Tuesday, September 26, 2023 10:39:10 AM
Recent SLNO News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:04:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/19/2024 09:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:03:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:02:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:02:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 01:01:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:00:20 PM
- Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome • GlobeNewswire Inc. • 06/28/2024 12:00:00 PM
- Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/24/2024 09:18:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 12:52:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 12:51:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 12:50:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:29:59 PM
- Soleno Therapeutics Set to Join Russell 3000® Index • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024 • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- Soleno Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/22/2024 12:00:00 PM
- Soleno Therapeutics Stands with the Prader-Willi Syndrome Community • GlobeNewswire Inc. • 05/15/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:31:17 PM
- Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 09:28:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2024 08:58:44 PM
- Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock • GlobeNewswire Inc. • 05/03/2024 02:32:12 AM
- Soleno Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 05/02/2024 08:01:37 PM
- Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM